A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Clinical trial NCT06362369 · RECRUITING

Trial details

NCT number: NCT06362369
Sponsor: 7 Hills Pharma, LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Cancer Advanced Solid Tumor Melanoma Metastasis Pleural Mesothelioma Renal Cell Carcinoma MSI-High Mismatch Repair Deficiency Colorectal Cancer Hepatocellular Carcinoma Hepatocellular Cancer Renal Cell Cancer

Start date: 2024-08-23
Primary completion: 2027-12-31
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.